Summary
CVS Health Corporation reported strong revenue growth in the second quarter and first half of 2016, driven by its recent acquisitions of Omnicare and Target's pharmacies and clinics. Net revenues increased by 17.6% and 18.3% for the three and six-month periods, respectively. While gross profit dollars saw a healthy increase, the gross profit margin declined year-over-year due to a shift in business mix and ongoing pricing and reimbursement pressures across both the Pharmacy Services and Retail/LTC segments. A significant event impacting profitability was a substantial loss of $542 million on the early extinguishment of debt during the quarter, primarily related to refinancing efforts. This loss, combined with a slight increase in interest expense due to recent debt issuances to fund acquisitions, impacted net income, which decreased year-over-year. Despite these impacts, the company continues to execute its share repurchase program, demonstrating a commitment to returning capital to shareholders.
Financial Highlights
56 data points| Revenue | $43.73B |
| Cost of Revenue | $36.71B |
| Gross Profit | $7.01B |
| Operating Expenses | $4.66B |
| Operating Income | $2.36B |
| Interest Expense | $284.00M |
| Net Income | $924.00M |
| EPS (Basic) | $0.86 |
| EPS (Diluted) | $0.86 |
| Shares Outstanding (Basic) | 1.07B |
| Shares Outstanding (Diluted) | 1.07B |
Key Highlights
- 1Net revenues increased significantly, up 17.6% for the quarter and 18.3% for the first half of 2016, largely due to the acquisitions of Omnicare and Target's pharmacies and clinics.
- 2Gross profit dollars increased, but gross profit margins decreased year-over-year due to business mix changes and pricing/reimbursement pressures.
- 3A substantial loss of $542 million was incurred from the early extinguishment of debt, impacting profitability for the period.
- 4Operating expenses increased, primarily due to integration costs from recent acquisitions, although they decreased as a percentage of net revenues due to revenue leverage.
- 5Net income decreased compared to the prior year, influenced by the debt extinguishment loss and higher interest expenses.
- 6The company actively managed its capital structure, issuing new debt and repurchasing approximately $4 billion of its common stock in the first half of 2016.
- 7Pharmacy Services segment showed revenue growth driven by claims volume and specialty pharmacy, while Retail/LTC benefited from store additions and pharmacy same-store sales increases, despite front-store sales declines.